| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3204529 | Journal of the American Academy of Dermatology | 2016 | 10 Pages |
Abstract
Increasing HCQ doses to reach blood concentrations greater than 750Â ng/mL should be considered before addition of other treatments in refractory CLE.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
François MD, Laurent MD, PhD, Nathalie MD, PhD, Noel PharmD, PhD, Didier MD, Camille MD,